Sponsors

Specific ELISA for varicella immune status

Binding Site’s new VaccZyme VZV glycoprotein IgG low-level enzyme-linked immunosorbent assay (ELISA) is a sensitive and specific quantitative assay for use in the accurate determination of immune status to varicella zoster virus (VZV), an important test for immunocompromised patients and pregnant women.

The kit has a high sensitivity measuring range of 10–810 miu/mL, which is ideal for the accurate measurement of post-vaccination antibody levels. High assay specificity is achieved using purified viral glycoprotein as the capture antigen, in common with the ‘gold standard’ FAMA reference method, rather than the viral cell lysate used in many alternative assays. In addition, the VaccZyme VZV glycoprotein ELISA is easily automated.
www.bindingsite.co.uk

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026

Microbiology Society Annual Conference 2026

ICC Belfast, Northern Ireland
13 - 16 April, 2026